Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Exchange Rate Effect (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Exchange Rate Effect for 16 consecutive years, with -$65000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 50.0% to -$65000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86000.0 through Dec 2025, up 279.17% year-over-year, with the annual reading at $86000.0 for FY2025, 279.17% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$65000.0 at Anika Therapeutics, up from -$302000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $345000.0 in Q2 2025, with the low at -$302000.0 in Q3 2025.
  • Average Exchange Rate Effect over 5 years is $2800.0, with a median of -$13000.0 recorded in 2022.
  • The sharpest move saw Exchange Rate Effect skyrocketed 850.0% in 2023, then crashed 929.63% in 2024.
  • Over 5 years, Exchange Rate Effect stood at $118000.0 in 2021, then crashed by 158.47% to -$69000.0 in 2022, then soared by 210.14% to $76000.0 in 2023, then tumbled by 271.05% to -$130000.0 in 2024, then surged by 50.0% to -$65000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$65000.0, -$302000.0, and $345000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.